Generic Medicine Info
Indications and Dosage
Disorders associated with reduced gastrointestinal motility
Adult: As anhydrous citrate: 5 mg tid.
Special Precautions
Continuous admin of this drug is not recommended if no improvement in GI symptoms is observed after 2 wk of admin. Elderly, renal impairment, hepatic impairment.
Adverse Reactions
Diarrhoea, abdominal pain; dizziness; constipation; headache; insomnia; nausea.
Drug Interactions
Mosapride concentration increased by erythromycin. May increase risk of QT prolongation with QT prolonging drugs.
Description: Mosapride is a 5-HT4 receptor agonist which increases the release of acetylcholine and stimulates GI motility. It also has 5-HT3 antagonist properties.
MIMS Class
GIT Regulators, Antiflatulents & Anti-Inflammatories
Disclaimer: This information is independently developed by MIMS based on Mosapride from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in